What does EndoKor do?

EndoKor is a specialist medical practice in Holsbeek. Private Limited, started on 6 March 2020, 1 establishment.

What is the address of EndoKor?

The registered office of EndoKor is located at Sint-Geertruibos 12, 3220 Holsbeek.

Is EndoKor still active?

Yes. According to the CBE (15 November 2026) EndoKor is active, legal situation “Normale toestand”, started on 6 March 2020.

Is EndoKor registered on Peppol?

Yes, EndoKor is registered on the Peppol network with ID 0208:0744832811.

What is the enterprise number of EndoKor?

The enterprise number of EndoKor is BE0744832811.

When was EndoKor founded?

EndoKor was founded on 6 March 2020.

Who are the directors of EndoKor?

According to the 2025 annual accounts, the directors of EndoKor are: Da-Hae Lee.

Is EndoKor a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 March 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did EndoKor make in 2025?

EndoKor posted a profit after taxes of € 315,211 in financial year 2025.

What is the revenue of EndoKor?

As a small company, EndoKor is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 442,914.

EndoKor (Private Limited) - Holsbeek - BE0744832811

Dossier EndoKor, printed on 15 November 2026 from databakkes.be/en/0744832811/endokor. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 25 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

EndoKor from Holsbeek, company number BE0744832811, closed financial year 2025 with a result of € 315,211 after tax. For that financial year EndoKor recorded a gross margin of € 442,914 and equity of € 68,594. Compared with financial year 2024, the result moved from € 285,031 to € 315,211. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 21, 2026.

What it is worth Healthy

€ 68,594

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 315,211

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 76,121

▼ 59% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 315,500 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 101,516

▼ 15% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 9,423

▲ 71% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,218

▼ 18% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 200,380 Gross margin 2022: € 200,380 First fiscal year in the series	€ 331,459 Gross margin 2023: € 331,459 ▲ 65% vs 2022 (€ 200,380) Favourable step	€ 389,195 Gross margin 2024: € 389,195 ▲ 17% vs 2023 (€ 331,459) Favourable step	€ 442,914 Gross margin 2025: € 442,914 ▲ 14% vs 2024 (€ 389,195) Favourable step	▲ 14%
Profit after taxes	€ 149,527 Profit after taxes 2022: € 149,527 First fiscal year in the series	€ 243,361 Profit after taxes 2023: € 243,361 ▲ 63% vs 2022 (€ 149,527) Favourable step	€ 285,031 Profit after taxes 2024: € 285,031 ▲ 17% vs 2023 (€ 243,361) Favourable step	€ 315,211 Profit after taxes 2025: € 315,211 ▲ 11% vs 2024 (€ 285,031) Favourable step	▲ 11%
Equity	€ 113,992 Equity 2022: € 113,992 First fiscal year in the series	€ 69,352 Equity 2023: € 69,352 ▼ 39% vs 2022 (€ 113,992) Unfavourable step	€ 68,883 Equity 2024: € 68,883 ▼ 1% vs 2023 (€ 69,352) Unfavourable step	€ 68,594 Equity 2025: € 68,594 Unchanged (€ 68,883) Unfavourable step
Total debts	€ 270,344 Total debts 2022: € 270,344 First fiscal year in the series	€ 329,911 Total debts 2023: € 329,911 ▲ 22% vs 2022 (€ 270,344) Unfavourable step	€ 301,029 Total debts 2024: € 301,029 ▼ 9% vs 2023 (€ 329,911) Favourable step	€ 333,142 Total debts 2025: € 333,142 ▲ 11% vs 2024 (€ 301,029) Unfavourable step	▲ 11%
Cash	€ 39,535 Cash 2022: € 39,535 First fiscal year in the series	€ 52,944 Cash 2023: € 52,944 ▲ 34% vs 2022 (€ 39,535) Favourable step	€ 183,791 Cash 2024: € 183,791 ▲ 247% vs 2023 (€ 52,944) Favourable step	€ 76,121 Cash 2025: € 76,121 ▼ 59% vs 2024 (€ 183,791) Unfavourable step	▼ 59%
Land & buildings	€ 42,754 Land & buildings 2022: € 42,754 First fiscal year in the series	€ 44,081 Land & buildings 2023: € 44,081 ▲ 3% vs 2022 (€ 42,754) Unchanged	€ 51,697 Land & buildings 2024: € 51,697 ▲ 17% vs 2023 (€ 44,081) Unchanged	€ 59,286 Land & buildings 2025: € 59,286 ▲ 15% vs 2024 (€ 51,697) Unchanged	▲ 15%
Retained profit	€ 110,992 Retained profit 2022: € 110,992 First fiscal year in the series	€ 66,352 Retained profit 2023: € 66,352 ▼ 40% vs 2022 (€ 110,992) Unfavourable step	€ 65,883 Retained profit 2024: € 65,883 ▼ 1% vs 2023 (€ 66,352) Unfavourable step	€ 65,594 Retained profit 2025: € 65,594 Unchanged (€ 65,883) Unfavourable step
Dividend	€ 175,000 Dividend 2022: € 175,000 First fiscal year in the series	€ 288,000 Dividend 2023: € 288,000 ▲ 65% vs 2022 (€ 175,000) Unchanged	€ 285,500 Dividend 2024: € 285,500 ▼ 1% vs 2023 (€ 288,000) Unchanged	€ 315,500 Dividend 2025: € 315,500 ▲ 11% vs 2024 (€ 285,500) Unchanged	▲ 11%
Balance sheet total	€ 384,336 Balance sheet total 2022: € 384,336 First fiscal year in the series	€ 399,263 Balance sheet total 2023: € 399,263 ▲ 4% vs 2022 (€ 384,336) Unchanged	€ 369,912 Balance sheet total 2024: € 369,912 ▼ 7% vs 2023 (€ 399,263) Unchanged	€ 401,736 Balance sheet total 2025: € 401,736 ▲ 9% vs 2024 (€ 369,912) Unchanged	▲ 9%

By gross margin, EndoKor ranks 2nd of 11 companies with main activity “Activiteiten van medisch specialisten” in Holsbeek that publish figures (fiscal year 2025).

Key figures of EndoKor, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about EndoKor the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to EndoKor?

What happened at EndoKor in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 21, 2026 New annual accounts for financial year 2025: profit of € 315,211 (▲ 11% vs 2024). Source: NBB ↗
Mar 10, 2020 Incorporation, published in the Gazette. Source: Staatsblad ↗
Mar 6, 2020 New establishment in Holsbeek. KBO
2020 Da-Hae Lee became a director. NBB